Form 4: Cibus Inc. Executive Sells Shares Under 10b5-1 Trading Plan

Gregory Francis William Gocal, Chief Scientific Officer & EVP of Cibus, Inc., sold 2,000 shares of Class A Common Stock at an average price of $10.0113 per share on July 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 15, 2024, Gregory Francis William Gocal, the Chief Scientific Officer & EVP of Cibus, Inc., sold 2,000 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $10.0113 per share, with individual transactions ranging from $10.00 to $10.03.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 27, 2024.
• Following the reported transaction, Gocal still beneficially owns 314,844 shares of Cibus, Inc.
• The sale was reported on a Form 4 filing with the SEC on July 17, 2024.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales by company executives are a normal part of corporate activity. The fact that this sale was executed under a 10b5-1 trading plan suggests it was pre-planned and intended to avoid any appearance of insider trading.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates